Image

Comparing Endoscopic Ultrasound vs Surgical Gastrojejunostomy for Management of GOO.

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this interventional study is to learn about the outcomes between two options for the management of malignant gastric outlet obstruction.

Description

The goal of this interventional study is to learn about the outcomes between two options for the management of malignant gastric outlet obstruction. The main question this study aims to answer is:

  1. To compare the rates of procedure related adverse events (AE's) between patients undergoing Endoscopy Ultrasound-guided gastro-jejunostomy (EUS-GJ) and Surgical gastro-jejunostomy (S-GJ).

Study participants will be randomized into one of the two standard procedures and followed for up to 12 months post procedure for collection of outcomes related data

Eligibility

Inclusion Criteria:

  1. ≥ 18 years of age.
  2. Radiographic OR Endoscopic evidence of an obstructing neoplasm in the distal stomach or duodenum.
  3. GOOSS of 0 or 1
  4. BOTH surgical and endoscopic GJ are technically and clinically feasible
  5. Can understand and is willing to sign informed consent form prior to the initiation of any study procedures (or when applicable the subject's LAR).

Exclusion Criteria:

  1. < 18 years of age
  2. ECOG >2
  3. Expected survival (determined by the treating oncologist) is less than 2 months.
  4. Candidates for potential resection of the cancer and obstructed anatomical area (this includes patients with borderline resectable pancreatic cancer)
  5. Peritoneal carcinomatosis with associated bowel obstruction on imaging or during laparoscopy
  6. Large volume ascites (patients with moderate volume ascites may undergo IR guided drainage prior to randomization)
  7. Anatomical factors that technically hinder EUS-GJ OR Surgical-GJ (diffuse tumor involvement in path of LAMS or surgery, surgically altered anatomy that interferes with the ability to perform an anastomosis etc)
  8. Pregnancy

Study details

Malignant Gastric Outlet Obstruction

NCT06128018

AdventHealth

20 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.